Darcy Lewis

Throughout medical school and into residency, Edward “Donnell” Ivy, MD, MPH, wanted to become a pediatrician, so he could help children avoid the suffering he’d experienced as a child with sickle cell disease (SCD). But the training didn’t quite match up with his expectations.
“It’s not enough to have all these good therapies to treat a disease if you’re not able to actually deliver those therapies to the patients who need them,” Ivy said.

CHICAGO — The Persian Gulf nation of Oman, located at the crossroads of Africa and Asia, presents a diverse ecosystem of patients with sickle cell disease (SCD), including a unique genotype specific to the country.
This diversity may prove instructive in managing SCD in a variety of countries, said Salam Alkindi, MD, hematologist-oncologist at Sultan Qaboos University, Muscat, Oman, presenting in a session at the 2025 Sickle Cell Disease Association of America national convention.

Lung cancer has been the leading cause of cancer death in the United States for many years. And it accounts for about 1 in 5 of all cancer deaths throughout the country. In fact, more Americans die from lung cancer than from breast, prostate and colon cancer combined.
The American Cancer Society (ACS) estimates that about 125,000 Americans will die from lung cancer this year — and about 60,000 of those will be women.

Motion-preserving technologies are driving a new era of designs for spine implants. From artificial discs to dynamic stabilization systems, these solutions aim to maintain the spine’s natural biomechanics while effectively treating spinal conditions.
Device developers are prioritizing minimally invasive approaches and creating implants with smaller profiles and modular designs for easier surgical delivery. New technologies are meeting the growing interest in solutions that are shifting from r...

Oral cancer, or mouth cancer, occurs when cells in your mouth grow in abnormal ways. About 60,000 people develop cancer in the tissues of their mouth, tongue, or throat each year. Oral cancers are a type of head and neck cancer.
You may not notice oral cancer symptoms at first. Seeing a dentist regularly is one way to detect oral cancers early. Here’s what you should know about the signs of mouth cancer.
What Is the Oral Cavity?
All the parts of your mouth make up your oral cavity. These part...

Sexual health is an important part of overall health. Understanding sexual health can complicate things even at the best of times. Sexual health during cancer treatment can feel; even more confusing.
Maintaining sexual health during cancer treatment is possible. Like other types of treatment, some people have side effects, while others don’t.

Cancer and its treatments can affect both your body and your mind. Treatments like chemotherapy and radiation therapy work hard to fight the disease. But they can also cause side effects that change how you feel day to day.
Knowing what to expect can help you feel more prepared. It also helps you understand how side effects might impact your routine and what you can do to feel better.

The human papillomavirus (HPV) is a sexually transmitted infection, meaning it travels between sexual partners. Of the more than 100 types of the virus, about 40 can spread through direct sexual contact, according to the Centers for Disease Control and Prevention (CDC).
HPV also causes many types of cancer. The American Cancer Society reports that 37,000 people in the United States receive an HPV-related cancer diagnosis each year.
Fortunately, an HPV vaccine is available.

Two targeted therapies used together extend survival for advanced non-small cell lung cancer but come with side effects.
LUNG CANCER REMAINS the leading cause of cancer death in the U.S., but for locally advanced or metastatic non-small cell lung cancer (NSCLC), treatment options have expanded in the past decade. Data from a clinical trial show two of these regimens used together can improve survival for people whose cancer expresses certain mutations, but the combination could come with qual...

Not every day does an investigator, while still a medical student, stumble upon an under-researched facet of medicine and identify what could turn out to be her life’s work. But that’s what happened when Hematologist Lauren Merz, MD, MSc, now an assistant professor at Rogel Cancer Center at the University of Michigan in Ann Arbor, Michigan, first learned about “benign ethnic neutropenia.”
Back in the day, Merz was a medical student at Michigan, writing a case report about a child with this di...

Lisa Holle, Nick Kalogriopoulos, and Paula Voorheis expand the School’s expertise in oncology, therapeutics, and health system innovation
From reimagining cancer care and exploring new therapeutic targets to reshaping how patients interact with the health system, new faculty joining the University of Wisconsin–Madison School of Pharmacy are bringing expertise to tackle some of the most pressing challenges in healthcare.

In 2018, after nearly a decade as managing principal of the Boston-based health equity organization Health Leads, Alexandra Quinn was ready for a change—she thought that would mean leaving the organization. Instead, and much to her surprise, she became its CEO.
“It turned out the organization was ready for a shift from just our initial focus on connecting families with essential resources,” Quinn said. “Part of the reason I said yes to this job was to squarely plant the flag on the fact that ...